MedTech Intelligence

1 month ago | medtechintelligence.com | Rick Biros

The U.S. Department of Health and Human Services (HHS) announced a dramatic restructuring in accordance with President Trump’s Executive Order, “Implementing the President’s ‘Department of Government Efficiency’ Workforce Optimization Initiative.”The restructuring will address this and serve multiple goals without impacting critical services.

2 months ago | medtechintelligence.com | Rick Biros

The Associated Press reported barely a week after mass firings at the Food and Drug Administration, some probationary staffers received unexpected news over the weekend: The government wants them back. Beginning Friday night, FDA employees overseeing medical devices received calls and emails notifying them that their recent terminations had been “rescinded effective immediately,” according to messages viewed by AP.

2 months ago | medtechintelligence.com | Rick Biros

The Associated Press reported that Elizabeth Holmes lost her bid to overturn her conviction, leaving the founder of the defunct blood-testing technology startup Theranos with few remaining legal options. Holmes appears to be headed for prison after an appeals court Tuesday rejected her bid to remain free while she tries to overturn her conviction in a blood-testing hoax that brought her fleeting fame and fortune.

2 months ago | medtechintelligence.com | Rick Biros

The Guardian reported that the Trump administration’s effort to slash the size of the federal workforce reached the Food and Drug Administration this weekend, as recently hired i.e. probationary employees, (employed at FDA for under three years) who review the safety of medical devices, food ingredients and other products were fired. On February 15, Probationary employees across the FDA received emails on Saturday evening that their jobs were being eliminated.

Jan 2, 2025 | medtechintelligence.com | Matt Burton

The United States is currently under the spotlight as Donald Trump’s recent appointment and consequent nomination of Robert F. Kennedy Jr as Department of Health and Human Services secretary are likely to bring a series of crucial changes that will affect the medical device market globally. Manufacturers everywhere are addressing their attention to the US market and waiting for new decisions to be made. In particular, deregulation is on the cards for the sector and the biggest concern is the restructure of the Food and Drug Administration (FDA), as a reduction in regulatory red-tape, though favoring increased competition, could also dangerously shrink examination processes.